Louis Denis - Concepedia

Author

Louis Denis

Erasmus MC

Also Known As

Denis, Louis, L Denis, LOUIS J. DENIS, Louis Denis, Louis J Denis, Louis J. Denis, van Bommel, Annelotte C.M.

153

Publications

15.4K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Provincial Institute for Hygiene Memorial Sloan Kettering Cancer Center Kantonsspital Aarau

About

Louis Denis is an author at Erasmus MC specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	6.4K
2	Public Health	6	6	2.8K
3	Health Sciences	1	1	11
4	Biostatistics	1	1	287
5	Cell Biology	1	1	21

Louis Denis

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Screening and Prostate-Cancer Mortality in a Randomized European Study Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, New England Journal of Medicine	2009	4K
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, European Urology Individual PatientsUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicine	2006	2.9K
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, The Lancet Prostate Cancer MortalityUrologyCancer EpidemiologyCancer ScreeningMedicine	2014	1.5K
Prostate-Cancer Mortality at 11 Years of Follow-up Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, New England Journal of Medicine	2012	1.2K
Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies Manuel Hidalgo, Lillian L. Siu, John Nemunaitis, Journal of Clinical Oncology	2001	997
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer Jonas Hugosson, Monique J. Roobol, Marianne Månsson, European Urology 16-Yr Follow-upUrologyCancer EpidemiologyCancer DetectionCancer Screening	2019	669
Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors Alain C. Mita, Louis Denis, Eric K. Rowinsky, Clinical Cancer Research	2009	328
Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial Harry J. de Koning, Anssi Auvinen, A. Berenguer Sánchez, International Journal of Cancer Erspc Trial RangeEpidemiology Of CancerCancer TrialProstate Cancer TrialOvary Cancer Trial	2001	287
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) Monique J. Roobol, Melissa Kerkhof, Fritz H. Schröder, European Urology Screening AdjustedUrologyCancer EpidemiologyCancer DetectionCancer Screening	2009	212
Staging of early prostate cancer: A proposed tumor volume-based prognostic index David G. Bostwick, Sam D. Graham, Pavel Napalkov, Urology	1993	146

Page 1